Mondaq Asia Pacific: Food, Drugs, Healthcare, Life Sciences
Ropes & Gray LLP
Beginning June 1, 2015, the vast majority drugs in China, except for narcotic and Type 1 psychotropic drugs, will be free from government-set pricing.
King & Wood Mallesons
The article discusses three highlights of the newly amended Drug Administration Law relating to registration and price.
Ropes & Gray LLP
China’s top legislature, the Standing Committee of National People’s Congress, recently approved the amendments (the "Amendments") to the Drug Administration Law.
Foley & Lardner
This post is the fifth in Foley’s blog series, "Realizing the Potential of Telemedicine in China," meant to address top issues facing U.S. companies looking to enter the Chinese telemedicine market.
Ropes & Gray LLP
The Center for Drug Evaluation (the "CDE") under the China Food and Drug Administration published final biosimilars guidance on February 28 with immediate effect.
King & Wood Mallesons
This article reviews highlights of the recent amendments and discusses the provisions of the Second Revised Amendment.
King & Wood Mallesons
This series of regulatory actions demonstrate efforts to strengthen the administration of medical devices and equipment.
Ropes & Gray LLP
The CFDA expects all device companies to comply with the New GMP and GSP rules as long as they intend to sell the products in China.
Ropes & Gray LLP
On November 21, 2014, China Food and Drug Administration ("CFDA") released a Draft Guidance on Multi-Regional Clinical Trials (Provisional) ("Guidance") for public comments through December 21.
King & Wood Mallesons
Reflections focus on the topics of: response time; response attitude; internal PR teams and official press conferences.
Ropes & Gray LLP
The Center for Drug Evaluation of the China Food and Drug Administration published a long-awaited guidance document for companies seeking to develop biosimilars.
Broad & Bright
People are growing increasingly conscientious about their health, and the pharmaceutical industry has become an important part of the national economy.
Ropes & Gray LLP
China’s health authority, the National Health and Family Planning Commission, released the Administrative Measures for the Clinical Study Projects of Medical Institutions.
Foley & Lardner
This post is the second in Foley’s blogs on China telemedicine and the first in the blog series, "Realizing the Potential of Telemedicine in China," meant to address top issues facing U.S. companies looking to enter the Chinese telemedicine market. We hope to expand the series to include additional issues.
Foley & Lardner
Telemedicine providers and vendors doing business in China, whether based in China, the United States, or elsewhere, received new guidance on the use of telemedicine.
Jones Day
Two individuals will be prosecuted shortly in Shanghai for conducting illegal investigations and purchase of personal information in China.
Jones Day
China continues to struggle in its efforts to improve food safety regulation and oversight, in the wake of a succession of food safety problems.
Ropes & Gray LLP
The amended Regulation for the Supervision and Administration of Medical Devices (the "Regulation," also known as the State Council Order No. 650), which came into force on June 1, 2014, set the new framework for China’s device regulatory regime.
King & Wood Mallesons
This newsletter discusses the differences between the Amendment and the Revised Amendment, and the underlying rationale.
PSA Legal Counsellors
These days, the demand for special food items like neutratceuticals and dietary supplements has increasingly been growing by leaps and bounds.
Most Popular Recent Articles
Vaish Associates Advocates
The Indian Medical Device industry has shown remarkable variation in its synthesis of demand and supply.
Singh & Associates
A highly organized sector, the Indian pharmaceutical industry is estimated to be worth $ 4.5 billion, growing at about 8 to 9 percent annually.
Singh & Associates
Indian Pharmaceutical Industry is at present, at its most progressive era where it has witnessed a robust growth over the past few years.
Russin & Vecchi
Understanding Vietnamese laws and regulations concerning food can be a challenge. The confusion results from the lack of a unified food law. Instead, the government relies primarily on laws which regulate the quality of goods in general. There are also specific regulations that apply these laws to food products. This means that there are two sets of regulations, one covering goods in general, and the other covering food products, and they often overlap.
Singh & Associates
Hon'ble Apex Court has recently awarded a historic verdict having a major impact on medical negligence and standard of medical care in India.
Clyde & Co
We will keep you informed of any developments with respect to the Discussion Paper, the Bill and the implementation of Prudential Standards by APRA with respect to private health insurers.
Singh & Associates
In today's era pharma industry is one of the most promising industry having huge profits, growth, knowledge and possibilities.
Singh & Associates
The Indian pharmaceutical industry is emerging as one of the most prospective markets in the global strata in terms of its potential.
Singh & Associates
In absence of the price list, it becomes difficult to the NPPA to regulate/fix/monitor the prices of scheduled formulation and non scheduled formulations.
Singh & Associates
On 24th February 2015, the Indian Patent office refused Bayer Healthcare AG'S attempt to patent tosylate salt form of its anticancer drug Sorafenib, known under the brand name Nexavar.
Article Search Using Filters
Related Topics
Popular Authors
Popular Contributors
Tools
Font Size:
Translation
Channels
Mondaq on Twitter